BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1551761)

  • 1. [Diagnostic strategies for evaluating lipid metabolism disorders and therapeutic goals].
    Cremer P; Nagel D
    Internist (Berl); 1992 Jan; 33(1):32-7. PubMed ID: 1551761
    [No Abstract]   [Full Text] [Related]  

  • 2. [Status quo of lipid diagnosis from the internal medicine viewpoint].
    Reuter W
    Z Gesamte Inn Med; 1988 Feb; 43(3):71-4. PubMed ID: 3369219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The risk and treatment of hyperlipoproteinemias].
    Alzamora P; Alegría E; Iglesias I
    Rev Med Univ Navarra; 1990; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems].
    von Essen R
    Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathophysiologic aspects of hyperlipoproteinemias].
    Soska V
    Vnitr Lek; 2000 Sep; 46(9):506-9. PubMed ID: 11344641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of blood profile of atherogenic lipids using immunologic techniques].
    Fruchart JC; Bard JM; Clavey V; Fievet C
    Klin Wochenschr; 1990; 68 Suppl 22():43-5. PubMed ID: 2087078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modern and general practice-oriented lipid and lipoprotein diagnosis].
    Luley C; Orth M; Wieland H
    Z Arztl Fortbild (Jena); 1992 Jun; 86(11):541-6. PubMed ID: 1621397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current strategies in the diagnosis and therapy of hyperlipoproteinemias].
    Riesen WF
    Schweiz Rundsch Med Prax; 1992 Jan; 81(3):49-54. PubMed ID: 1733003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of hemosorption on the lipid and lipoprotein composition of the blood plasma].
    Perepelitsa VN
    Vrach Delo; 1990 Jun; (6):32-4. PubMed ID: 2399714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hyperlipoproteinemias.
    Patsch W; Patsch JR; Gotto AM
    Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New aspects in lipidology and atherosclerosis.
    Superko HR
    Can J Cardiol; 1995 May; 11 Suppl C():4C-8C. PubMed ID: 7750049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retinoids and lipid metabolism].
    Melnik B; Plewig G
    Hautarzt; 1986 Jun; 37(6):304-11. PubMed ID: 3721869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters].
    Herrmann W; Lackner KJ; Schmitz G
    Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dyslipoproteinemia: its importance in nephrology].
    Ritz E; Matthias S; Fliser D
    Z Kardiol; 1993; 82 Suppl 4():49-55. PubMed ID: 8147062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoproteins and ischemic vascular disease: on the interpretation of serum lipid versus serum lipoprotein concentrations.
    Rössner S
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S201-5. PubMed ID: 6177957
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma lipids and coronary atherosclerosis in Japanese men.
    Nakaya Y; Hiasa Y; Morimoto S
    Tokushima J Exp Med; 1993 Dec; 40(3-4):177-82. PubMed ID: 8184414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipid metabolism and lipid utilization in renal failure].
    Druml W; Laggner A; Lenz K; Balcke P; Kleinberger G; Schmidt P
    Infusionsther Klin Ernahr; 1983 Aug; 10(4):206-12. PubMed ID: 6618660
    [No Abstract]   [Full Text] [Related]  

  • 20. [Simple and reliable scheme for determining lipid metabolic disturbances].
    Tel'nov VI; Tokarskaia ZB
    Lab Delo; 1981; (11):643-7. PubMed ID: 6170810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.